The question was addressed by Brian Shirts, MD, PhD, President of ConnectMyVariant and Service Medical Director of the Molecular Genetics Laboratories at Vanderbilt University Medical Center. If you have a question you would like addressed, email ICARE@vumc.org for consideration in future newsletters. Q: Why do you think cascade testing has not happened as much as …
Permanent link to this article: https://inheritedcancer.net/nlf202511/
Check out a recent article led by the ICARE team, published in the Journal of Genetic Counseling, outlining family communication of genetic test results among female BRCA1/2, PALB2, CHEK2, and ATM carriers. Check out the full article at: https://onlinelibrary.wiley.com/doi/full/10.1002/jgc4.1356
Permanent link to this article: https://inheritedcancer.net/post40221/
Once an individual has had genetic testing for inherited cancer predisposition this information could help their close family members. For example, when a BRCA mutation or a mutation in another inherited cancer gene is found, it is important for close family members (with or without a diagnosis of cancer) to know so they too can …
Permanent link to this article: https://inheritedcancer.net/1nlw2016/
